Trials / Terminated
TerminatedNCT03089073
Study of Minirin Melt® in Adult Patients With Nocturia
Non-interventional Study on Safety and Efficacy of Minirin Melt® in Adult Patients With Nocturia
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 835 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Observation of safety and efficacy of Minirin Melt® in adult patients with nocturia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desmopressin | 60μg or 120μg once daily at bedtime |
Timeline
- Start date
- 2015-07-13
- Primary completion
- 2018-10-05
- Completion
- 2018-10-05
- First posted
- 2017-03-24
- Last updated
- 2021-02-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03089073. Inclusion in this directory is not an endorsement.